255 related articles for article (PubMed ID: 31536753)
1. Phosphodiesterase inhibitors say NO to Alzheimer's disease.
Nabavi SM; Talarek S; Listos J; Nabavi SF; Devi KP; Roberto de Oliveira M; Tewari D; Argüelles S; Mehrzadi S; Hosseinzadeh A; D'onofrio G; Orhan IE; Sureda A; Xu S; Momtaz S; Farzaei MH
Food Chem Toxicol; 2019 Dec; 134():110822. PubMed ID: 31536753
[TBL] [Abstract][Full Text] [Related]
2. Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease.
Wu Y; Li Z; Huang YY; Wu D; Luo HB
J Med Chem; 2018 Jul; 61(13):5467-5483. PubMed ID: 29363967
[TBL] [Abstract][Full Text] [Related]
3. Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.
Prickaerts J; Heckman PRA; Blokland A
Expert Opin Investig Drugs; 2017 Sep; 26(9):1033-1048. PubMed ID: 28772081
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.
Xi M; Sun T; Chai S; Xie M; Chen S; Deng L; Du K; Shen R; Sun H
Eur J Med Chem; 2022 Mar; 232():114170. PubMed ID: 35144038
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview.
Heckman PR; Wouters C; Prickaerts J
Curr Pharm Des; 2015; 21(3):317-31. PubMed ID: 25159073
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.
Bobin P; Belacel-Ouari M; Bedioune I; Zhang L; Leroy J; Leblais V; Fischmeister R; Vandecasteele G
Arch Cardiovasc Dis; 2016; 109(6-7):431-43. PubMed ID: 27184830
[TBL] [Abstract][Full Text] [Related]
8. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
Kokkonen K; Kass DA
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
[TBL] [Abstract][Full Text] [Related]
9. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
10. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of phosphodiesterases in the treatment of cough.
Mokry J; Urbanova A; Kertys M; Mokra D
Respir Physiol Neurobiol; 2018 Nov; 257():107-114. PubMed ID: 29337269
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
14. Targeting New Pharmacological Approaches for Alzheimer's Disease: Potential for Statins and Phosphodiesterase Inhibitors.
Sallustio F; Studer V
CNS Neurol Disord Drug Targets; 2016; 15(6):647-59. PubMed ID: 27189469
[TBL] [Abstract][Full Text] [Related]
15. Anti-platelet therapy: phosphodiesterase inhibitors.
Gresele P; Momi S; Falcinelli E
Br J Clin Pharmacol; 2011 Oct; 72(4):634-46. PubMed ID: 21649691
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
17. Potential role of IP3/Ca
Jyoti Dutta B; Singh S; Seksaria S; Das Gupta G; Bodakhe SH; Singh A
Biochem Pharmacol; 2022 Jul; 201():115071. PubMed ID: 35525328
[TBL] [Abstract][Full Text] [Related]
18. Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer's Disease.
Sharma VK; Singh TG; Singh S
Curr Drug Targets; 2020; 21(13):1371-1384. PubMed ID: 32718286
[TBL] [Abstract][Full Text] [Related]
19. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors.
Uckert S; Bazrafshan S; Scheller F; Mayer ME; Jonas U; Stief CG
Urology; 2007 Jul; 70(1):185-9. PubMed ID: 17656245
[TBL] [Abstract][Full Text] [Related]
20. Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases.
Xiang Y; Naik S; Zhao L; Shi J; Ke H
Med Res Rev; 2024 Jul; 44(4):1404-1445. PubMed ID: 38279990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
